Mosanna Therapeutics raised an $80M Series A round co-led by Pivotal bioVenture Partners and EQT, with Forbion, Broadview Ventures, and Norwest Ventures.
01 June 2025
Belgium
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain